Halozyme Therapeutics

HALO13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying HALO

Top funds mostly added to Halozyme Therapeutics in Q2 (Apr⁠–⁠Jun)

Buying:

Funds1InsidersCongress

Top funds
1 of 2 bought more, 0 sold some. Largest: Torray Investment Partners, $3.0M (0% of its portfolio).
Insiders
No buys, 24 sales in 12 months.
Congress
1 member bought (1 trade), 1 sale in 12 months.

2 funds$3.3M held0.2% avg. weightQ2: 1 bought / 0 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 39 filings

Date	Insider	Type	Shares	Price	Value
Oct 6, 2026	Helen Torley President & CEO	Sold	60,000	$110.18	$6.61M
Oct 1, 2026	Matthew L. Posard Director	Sold	5,230	$108.54	$568K
Sep 16, 2026	Matthew L. Posard Director	Sold	18,996	$107.74	$2.05M
Sep 9, 2026	Helen Torley President & CEO	Sold	60,000	$107.28	$6.44M
Aug 17, 2026	Helen Torley President & CEO	Sold	60,000	$104.59	$6.28M
Aug 10, 2026	Bernadette Connaughton Director	Sold	1,626	$102.80	$167K
Jul 8, 2026	Helen Torley President & CEO	Sold	1,923	$79.77	$153K
Jul 1, 2026	Bernadette Connaughton Director	Sold	1,625	$76.71	$125K
Jun 29, 2026	Mahesh Krishnan Director	Sold	7,304	$75.00	$548K
Jun 1, 2026	Helen Torley President & CEO	Sold	50,000	$67.40	$3.37M
Jun 1, 2026	Bernadette Connaughton Director	Sold	1,625	$66.21	$108K
May 11, 2026	Helen Torley President & CEO	Sold	50,000	$68.68	$3.43M
May 1, 2026	Bernadette Connaughton Director	Sold	1,625	$63.48	$103K
Apr 6, 2026	Helen Torley President & CEO	Sold	10,000	$63.50	$635K
Apr 1, 2026	Helen Torley President & CEO	Sold	40,000	$64.81	$2.59M
Mar 9, 2026	Cortney Caudill VP & COO	Sold	28,857	$67.75	$1.96M
Mar 2, 2026	Helen Torley President & CEO	Sold	50,000	$69.52	$3.48M
Feb 3, 2026	Helen Torley President & CEO	Sold	50,000	$77.07	$3.85M
Jan 5, 2026	Bernadette Connaughton Director	Sold	2,000	$70.25	$141K
Nov 1, 2025	Cortney Caudill VP & COO	Sold	4,263	$65.19	$278K
Dec 1, 2025	Bernadette Connaughton Director	Sold	829	$71.60	$59K
Dec 1, 2025	Helen Torley President & CEO	Sold	16,569	$68.92	$1.14M
Nov 10, 2025	Helen Torley President & CEO	Sold	60,000	$69.47	$4.17M
Nov 10, 2025	Bernadette Connaughton Director	Sold	2,000	$68.48	$137K
Oct 1, 2025	Helen Torley President & CEO	Sold	60,000	$71.86	$4.31M
Oct 1, 2025	Bernadette Connaughton Director	Sold	2,000	$75.24	$150K
Sep 22, 2025	Nicole Labrosse VP & CFO	Sold	2,227	$77.95	$174K
Sep 10, 2025	Nicole Labrosse VP & CFO	Sold	20,000	$75.71	$1.51M
Sep 2, 2025	Helen Torley President & CEO	Sold	60,000	$74.08	$4.44M
Sep 2, 2025	Bernadette Connaughton Director	Sold	4,000	$73.68	$295K
Aug 11, 2025	Helen Torley President & CEO	Sold	60,000	$63.62	$3.82M
Jul 8, 2025	Helen Torley President & CEO	Sold	60,000	$56.46	$3.39M
Jun 20, 2025	Helen Torley President & CEO	Sold	60,000	$53.09	$3.19M
Apr 28, 2025	Jeffrey William Henderson Director	Sold	4,497	$60.37	$271K
Apr 1, 2025	Jeffrey William Henderson Director	Sold	503	$64.05	$32K
Mar 3, 2025	Jeffrey William Henderson Director	Sold	5,000	$58.69	$293K
Feb 25, 2025	Michael J. Labarre VP & CTO	Sold	21,697	$58.10	$1.26M
Feb 3, 2025	Jeffrey William Henderson Director	Sold	5,000	$56.30	$282K
Jan 6, 2025	Jeffrey William Henderson Director	Sold	10,000	$50.01	$500K